| Literature DB >> 29746560 |
Maria Luisa Marenzoni1, Lorenzo Santoni2, Andrea Felici3, Carmen Maresca3, Valentina Stefanetti1, Monica Sforna1, Maria Pia Franciosini1, Patrizia Casagrande Proietti1, Francesco Carlo Origgi4.
Abstract
Testudinid herpesviruses (TeHVs) have a worldwide distribution among tortoises. However, information such as risk factors promoting the occurrence or the recrudescence of the associated disease and the mid-term sequelae of an outbreak comprising the extent and dynamic of the viral shedding have been only minimally investigated. Critical management information is also lacking or anecdotal. Furthermore, major aspects of the viral pathogenesis including the likelihood of vertical transmission of the virus are virtually unknown. The present study describes the occurrence and the management of an outbreak of Testudinid herpesvirus genotype 3 (TeHV3) in a large, private collection of chelonians. Clinical, pathological, molecular and serological characterization of the outbreak were carried out. Seventy-five percent of the infected tortoises died. Complementation of molecular and serological testing was a critical point for successful management implementations. A case-control study was performed to analyze possible risk factors associated with the infection. Furthermore, a subgroup of six asymptomatic infected tortoises was monitored for two consecutive seasons after the outbreak: all the infected tortoises were determined to be intermittent shedders, except one, which was a persistent shedder. Post-hibernation was associated with the highest number of shedders. Finally, evidence of the most likely vertical transmission of the virus was obtained for the first time.Entities:
Mesh:
Year: 2018 PMID: 29746560 PMCID: PMC5944942 DOI: 10.1371/journal.pone.0197169
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Features of exposed tortoises during the TeHV3 outbreak.
| ID tortoise | species | sex | age (years) | location 2012 | location 2013, initial phase | location 2013, second phase | date of onset of clinical signs | list of clinical signs | date of death | herpes-viruses | serological result | antiviral treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | >30 | 1 | 3 | 0 | April 07, 2013 | ND | April 11, 2013 | + | nc | - | |
| 2 | M | >30 | 1 | 2 | 0 | April 12, 2013 | OD | April 20, 2013 | + | nc | - | |
| 3 | M | 10 | 1 | 4 | 0 | April 12, 2013 | OD | April 14, 2013 | + | nc | - | |
| 4 | M | >30 | 1 | 1 | 0 | April 12, 2013 | OD | April 22, 2013 | + | nc | - | |
| 5 | M | 10 | 1 | 1 | 0 | April 13, 2013 | OD; OP | April 14, 2013 | + | nc | - | |
| 6 | M | 10 | 1 | 4 | 4 | April 14, 2013 | OD | April 16, 2013 | + | nc | - | |
| 7 | M | 10 | 1 | 4 | 4 | April 14, 2013 | OD | April 17, 2013 | + | nc | - | |
| 8 | M | >30 | 1 | 4 | 4 | April 20, 2013 | OD | April 25, 2013 | + | nc | - | |
| 9 | M | 9 | 1 | 4 | 4 | April 20, 2013 | OD | April 26, 2013 | + | nc | - | |
| 10 | M | 9 | 4 | 4 | 4 | April 20, 2013 | OD; ND | June 17, 2013 | + | nc | - | |
| 11 | F | >30 | 2 | 2 | 3 | April 28, 2013; | OD; ND | May 21, 2013 | + | nc | - | |
| 12 | F | >30 | 2 | 1 | 2 | May 23, 2013 | OD; OP | June 22, 2013 | + | nc | + | |
| 13 | F | >30 | 2 | 1 | 2 | August, 2013 | OD; hind limb paresis | March 17, 2014 | + | nc | + | |
| 14 | F | >30 | 2 | 1 | 1 | - | No | - | + | nc | + | |
| 15 | F | >30 | 2 | 1 | 2 | - | No | July, 2013 | + | nc | + | |
| 16 | F | 10 | 2 | 3 | 2 | - | No | - | + | nc | - | |
| 17 | F | >30 | 2 | 3 | 2 | March, 2014 | ND | March, 2014 | + | nc | - | |
| 18 | M | 15 | 1 | 2 | 4 | March 17, 2014 | ND | August, 2014 | + | + | - | |
| 19 | M | 16 | 4 | 4 | 4 | - | No | - | + | + | - | |
| 20 | F | >30 | 2 | 1 | 2 | - | No | - | + | + | - | |
| 21 | F | >30 | 2 | 2 | 2 | - | No | - | - | - | - | |
| 22 | F | >30 | 2 | 2 | 2 | - | No | - | - | - | - |
M: male; F: female
ND: nasal discharge; OD: oral discharge; OP: oral plaques.
IS, intermittent shedder: the tortoise was alternatively positive or negative during the period of monitoring that lasted until December 2014 or until their death (whichever came first).
PS, persistent shedder: the tortoise was consistently positive during the period of monitoring that lasted until December 2014.nc = not conducted. These tortoises died before that the serological tests could be carried out.
^ Antiviral treatment consisted of acyclovir 80 mg/kg/day per os for 30 days.
†: Asymptomatic in the first year of the outbreak and with mild clinical signs the following year.
§: It had recurrent clinical signs
# hindlimb paresis (S1 Video) lasted all year long, even if with partial improvement. At the beginning of the occurrence of the paresis, the tortoise was able to lay 3 eggs. This tortoise partially recovered from the neurological signs, but died during post-hibernation the following year, after having had oral discharge. It was repeatedly positive for TeHV DNA (from OSW) during all the period until its death.
*The PCR was positive during the monitoring but not at the time of the death of the tortoise.
Oral discharge, characterized by the presence of dense mucus, was the main clinical sign, reported in 12 out of the 15 confirmed cases (80%). Nasal discharge (5/15, 33.3%), oral diphtheronecrotic plaques (2/15, 13.3%), neurologic signs (tortoise no. 13) were also present. The majority of the cases (9/15, 60%) died within 10 days from the onset of clinical signs, immediately after hibernation. The tortoises that presumptively became infected later on during the late spring/summer (nos. 10, 11, 12, and 13) had clinical signs that lasted for nearly one month before their death.
Fig 1Epidemic curve of the TeHV3 outbreak, April 2013-March 2014.
The curve was built using only the cases having clinical signs, for which it is possible to estimate an exact date of onset of the clinical signs. Bars represent longer periods of time that were cut in the figure. The pattern of the curve, with its irregular trend of cases reflecting the timing and extent of repeated exposures, is consistent with an intermittent source of infection. An estimation of the incubation period was attempted observing the gaps between the peaks of the curve that could represent tortoise-to-tortoise transmission events, followed by a possible incubation period. After the initial period, the outbreak waned, perhaps because of the successful and rapid implementation of control measures.
Fig 2Tortoise no. 7: Oral cavity, glottis.
Mucosal erosion and ulceration with marked spongiosis (intercellular oedema). Note the presence of intranuclear amphophilic inclusions in the epithelial cells (arrows) associated with margination of the nuclear chromatin. H&E, 400X.
Attack rate and pooled Odds Ratio (OR), with corresponding 95% confidence interval (95% CI), of different risk factors for the tortoises exposed to TeHV3 infection.
| Risk factor | cases and infected tortoises, | not infected tortoises, | total, | Attack rate (%) | OR | 95% CI | |
|---|---|---|---|---|---|---|---|
| species | |||||||
| | 3 | 21 | 24 | 12,5 | 1 | - | - |
| | 17 | 43 | 60 | 28,3 | 2,77 | 0,73–10,5 | 0,16 |
| gender | |||||||
| female | 8 | 19 | 27 | 29,6 | 1 | - | - |
| male | 12 | 9 | 21 | 57,1 | 3,17 | 0,96–10,57 | 0,05 |
| not indentified | 0 | 36 | 36 | 0 | na | na | |
| age | |||||||
| <10 years | 2 | 42 | 44 | 4,5 | 1 | - | - |
| ≥10 years | 18 | 22 | 40 | 45 | 17,18 | 3,65–80,88 | <0,001 |
| location of the 2012 | |||||||
| other enclosures | 2 | 58 | 58 | 3,5 | 1 | - | - |
| enclosure no.1 | 10 | 0 | 11 | 90,9 | 156,4 | 6,92–2367 | <0,001 |
| enclosure no. 2 | 8 | 7 | 15 | 53,3 | 20,67 | 3,89–109,6 | <0,001 |
| location of the 2013, initial phase | |||||||
| other enclosures | 0 | 62 | 62 | 0 | 1 | - | - |
| enclosure no.1 | 7 | 0 | 0 | 100 | 68,92 | 3,68–1291 | <0,001 |
| enclosure no.2 | 3 | 2 | 5 | 60 | 5,47 | 0,84–35,42 | 0,08 |
| enclosure no.3 | 3 | 0 | 3 | 100 | 22,59 | 1,08–472,7 | 0,01 |
| enclosure no.4 | 7 | 0 | 7 | 100 | 68,92 | 3,68–1291 | <0,001 |
| location of the 2013, second phase | |||||||
| other enclosures | 0 | 62 | 62 | 0 | 1 | - | - |
| enclosure no.1 | 1 | 0 | 1 | 100 | 9,14 | 0,29–286,1 | 0,27 |
| enclosure no.2 | 6 | 2 | 8 | 75 | 20,67 | 3,6–118,5 | <0,001 |
| enclosure no.3 | 1 | 0 | 1 | 100 | 9,14 | 0,29–286,1 | 0,27 |
| enclosure no.4 | 7 | 0 | 7 | 100 | 112 | 5,8–2165 | <0,001 |
1 Reference category.
na: not applied.
# The gender of the tortoises is not identified until they are 6 years old.
* All tortoises in this enclosure were male.
† All tortoises in this enclosure were female.
§The other infected tortoises were dead.